Literature DB >> 12367556

Myeloid dendritic cells in non-obese diabetic mice have elevated costimulatory and T helper-1-inducing abilities.

Annette M Marleau1, Bhagirath Singh.   

Abstract

Type 1 diabetes (T1D) in the non-obese diabetic (NOD) mouse begins with activation of islet-reactive T helper-1 (Th1) cells by dendritic cells (DCs). Since multiple genetic loci contribute to T1D, we evaluated the hypothesis that NOD DCs possess inherent characteristics that contribute to the autoimmune phenotype. When compared to a representative Th1 (C57BL/6) and Th2 (BALB/C) control strain, in vitro generated NOD myeloid DCs matured normally. Functionally, NOD DCs exhibited higher expression of CD80/86 and IL-12 production during stimulation of nai;ve T cells, even in comparison to C57BL/6 DCs, the prototype strain for vigorous, Th1-biased immunity. These features of NOD DCs translated into aberrantly elevated IFN-gamma synthesis, enhanced T-cell proliferation, and heightened CD69 expression. Further, NOR DCs, from an NOD-related, autoimmune-resistant strain, did not display this hyper-responsiveness, suggesting that these abnormalities are genetic features of NOD DCs that are related to disease pathogenesis. Cumulatively, these results indicate that NOD DCs are inherently biased towards abnormally high costimulation and Th1-induction, two features that would be expected to confer activation and persistence of autoreactive T cells.

Entities:  

Mesh:

Year:  2002        PMID: 12367556     DOI: 10.1006/jaut.2002.0597

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  13 in total

Review 1.  Dendritic cells, T cell tolerance and therapy of adverse immune reactions.

Authors:  P A Morel; M Feili-Hariri; P T Coates; A W Thomson
Journal:  Clin Exp Immunol       Date:  2003-07       Impact factor: 4.330

Review 2.  Dendritic cell immunotherapy for autoimmune diabetes.

Authors:  Maryam Feili-Hariri; Rafael R Flores; A Cecilia Vasquez; Penelope A Morel
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

3.  Dendritic cell-directed CTLA-4 engagement during pancreatic beta cell antigen presentation delays type 1 diabetes.

Authors:  Subha Karumuthil-Melethil; Nicolas Perez; Ruobing Li; Bellur S Prabhakar; Mark J Holterman; Chenthamarakshan Vasu
Journal:  J Immunol       Date:  2010-05-14       Impact factor: 5.422

4.  Impaired dendritic cell function in a spontaneous autoimmune polyneuropathy.

Authors:  Songhua Quan; Hye-Jung Kim; Danuta Dukala; Jian Rong Sheng; Betty Soliven
Journal:  J Immunol       Date:  2015-03-30       Impact factor: 5.422

5.  T cell hyperactivity in lupus as a consequence of hyperstimulatory antigen-presenting cells.

Authors:  Jiankun Zhu; Xuebin Liu; Chun Xie; Mei Yan; Ying Yu; Eric S Sobel; Edward K Wakeland; Chandra Mohan
Journal:  J Clin Invest       Date:  2005-06-09       Impact factor: 14.808

6.  Passive transfer of flt-3L-derived dendritic cells delays diabetes development in NOD mice and associates with early production of interleukin (IL)-4 and IL-10 in the spleen of recipient mice.

Authors:  J Morin; B Faideau; M-C Gagnerault; F Lepault; C Boitard; S Boudaly
Journal:  Clin Exp Immunol       Date:  2003-12       Impact factor: 4.330

Review 7.  Immunomodulation of autoimmune diabetes by dendritic cells.

Authors:  Klaus Pechhold; Kerstin Koczwara
Journal:  Curr Diab Rep       Date:  2008-04       Impact factor: 4.810

8.  Curcumin ameliorates autoimmune diabetes. Evidence in accelerated murine models of type 1 diabetes.

Authors:  C N Castro; A E Barcala Tabarrozzi; J Winnewisser; M L Gimeno; M Antunica Noguerol; A C Liberman; D A Paz; R A Dewey; M J Perone
Journal:  Clin Exp Immunol       Date:  2014-07       Impact factor: 4.330

9.  Involvement of SOCS3 in regulation of CD11c+ dendritic cell-derived osteoclastogenesis and severe alveolar bone loss.

Authors:  Xiaoxia Zhang; Mawadda Alnaeeli; Bhagirath Singh; Yen-Tung A Teng
Journal:  Infect Immun       Date:  2009-03-02       Impact factor: 3.441

10.  IFN regulatory factors 4 and 8 expression in the NOD mouse.

Authors:  Gilles Besin; Simon Gaudreau; Emilie Dumont-Blanchette; Michael Ménard; Chantal Guindi; Gilles Dupuis; Abdelaziz Amrani
Journal:  Clin Dev Immunol       Date:  2011-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.